Page last updated: 2024-10-24

caffeine and Multiple Myeloma

caffeine has been researched along with Multiple Myeloma in 2 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soriani, A1
Zingoni, A1
Cerboni, C1
Iannitto, ML1
Ricciardi, MR1
Di Gialleonardo, V1
Cippitelli, M1
Fionda, C1
Petrucci, MT1
Guarini, A1
FoĆ , R1
Santoni, A1
Greenwalt, TJ1
van Oss, CJ1
Steane, EA1

Other Studies

2 other studies available for caffeine and Multiple Myeloma

ArticleYear
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.
    Blood, 2009, Apr-09, Volume: 113, Issue:15

    Topics: Antibiotics, Antineoplastic; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Antineo

2009
Use of a tannic acid-caffeine concentration procedure for detecting urinary proteins and hemagglutinins.
    American journal of clinical pathology, 1968, Volume: 49, Issue:4

    Topics: Antibodies; Blood Group Antigens; Caffeine; Electrophoresis; Erythroblastosis, Fetal; Female; Humans

1968